0
Compass Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−81.9
FY22:
−41.7
FY23:
−50.4
FY24:
−56.6
FY25:
−72.8
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−39.8
FY23:
−48.5
FY24:
−54.9
FY25:
−71.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.2
FY22:
−39.2
FY23:
−42.5
FY24:
−49.4
FY25:
−66.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.2
FY22:
−39.2
FY23:
−42.5
FY24:
−49.4
FY25:
−66.5
All amounts in millions USD